People living with HIV in California were highly satisfied with telephone visits during the height of the COVID-19 pandemic ...

Edgardo S. Santos, MD, FACP, FASCO, discussed the barriers to precision medicine in lung cancer treatment, including patient ...

In this second part of our interview with Kasey Bond, MPH, NYU Langone Health, we discuss the contributions of community ...

The differences did not appear to be associated with potential moderating factors like age, sex, or smoking status.

T-cell therapy yielded encouraging response rates and safety findings among patients with relapsed or refractory chronic ...

A phase 3 trial highlights betibeglogene autotemcel as a potentially curative gene therapy for severe transfusion-dependent β ...

Tislelizumab-jsgr (Tevimbra) was approved in combination with chemotherapy for the treatment of unresectable or metastatic ...

A Mendelian analysis supports the idea that hyperuricemia may be an important risk factor for pulmonary arterial hypertension ...

The VET PFAS Act could help older veterans with toxic exposure attain the medical treatment they need by expanding ...

Patients with generalized myasthenia gravis experienced durable improvements across measures of efficacy and regardless of the time since they were diagnosed.

Tim Mok, PharmD, BCPS, BCOP, malignant hematology pharmacy research analyst at Kaiser Permanente, discussed his perspective on the balance between clinical outcomes and cost considerations.

Tiago Biachi, MD, PhD, discusses the challenges of treating gastrointestinal (GI) cancers, particularly the limited effectiveness of immunotherapy for "cold tumors" and the need to make them more ...